ORAL PRESENTATIONS: Saturday, 22 April 2017: Late breakers: Orals
LBO-03 - MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection

https://doi.org/10.1016/S0168-8278(17)30444-0Get rights and content

References (0)

Cited by (0)

View full text